ConductScience.org, home

Paper39239161

Loss to follow-up among adults with drug-resistant TB in Papua New Guinea.

Charles F and 6 others. Public Health Action, 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Loss to follow-up among adults with drug-resistant TB in Papua New Guinea. Papers, record 39239161. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39239161

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Loss to follow-up among adults with drug-resistant TB in Papua New Guinea.
PubMed
Journal
Public Health Action
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.42, provisional
iCite
Revised in PubMed
2024-09-10
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Charles FF
2Lin YDY D
3Greig JJ
4Gurra SS
5Morikawa RR
6Graham SMS M
7Maha AA

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131580333The emergency response to multidrug-resistant tuberculosis in Daru, Western Province, Papua New Guinea, 2014-2017.Public Health Action2019https://conductscience.org/library/papers/31580333PubMed
235524232Evolution and spread of a highly drug resistant strain of Mycobacterium tuberculosis in Papua New Guinea.BMC Infect Dis2022https://conductscience.org/library/papers/35524232PubMed
331579651Challenges in TB diagnosis and treatment: the Kavieng Provincial Hospital experience, Papua New Guinea.Public Health Action2019https://conductscience.org/library/papers/31579651PubMed
430332452Model of care and risk factors for poor outcomes in patients on multi-drug resistant tuberculosis treatment at two facilities in eSwatini (formerly Swaziland), 2011-2013.PLoS One2018https://conductscience.org/library/papers/30332452PubMed
534097769Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis.Cochrane Database Syst Rev2021https://conductscience.org/library/papers/34097769PubMed
636883701Beyond patient delay, navigating structural health system barriers to timely care and treatment in a high burden TB setting in Papua New Guinea.Glob Public Health2023https://conductscience.org/library/papers/36883701PubMed
729562985Rifampicin-resistant tuberculosis patients in Myanmar in 2016: how many are lost on the path to treatment?Int J Tuberc Lung Dis2018https://conductscience.org/library/papers/29562985PubMed
830057853Epidemiology of tuberculosis in Papua New Guinea: analysis of case notification and treatment-outcome data, 2008-2016.Western Pac Surveill Response J2018https://conductscience.org/library/papers/30057853PubMed
936962674Impacts of tuberculosis services strengthening and the COVID-19 pandemic on case detection and treatment outcomes in Mimika District, Papua, Indonesia: 2014-2021.PLOS Glob Public Health2022https://conductscience.org/library/papers/36962674PubMed
1031579645Impact of GxAlert on the management of rifampicin-resistant tuberculosis patients, Port Moresby, Papua New Guinea.Public Health Action2019https://conductscience.org/library/papers/31579645PubMed
1136048756Improving Estimates of Social Contact Patterns for Airborne Transmission of Respiratory Pathogens.Emerg Infect Dis2022https://conductscience.org/library/papers/36048756PubMed
1227003160The Burden of Drug-Resistant Tuberculosis in Papua New Guinea: Results of a Large Population-Based Survey.PLoS One2016https://conductscience.org/library/papers/27003160PubMed
1326393097Risk factors associated with loss to follow-up among multidrug-resistant tuberculosis patients in Georgia.Public Health Action2014https://conductscience.org/library/papers/26393097PubMed
1424623906Pre-treatment loss to follow-up in tuberculosis patients in low- and lower-middle-income countries and high-burden countries: a systematic review and meta-analysis.Bull World Health Organ2014https://conductscience.org/library/papers/24623906PubMed
1531579644Drug-resistant tuberculosis diagnosis since Xpert® MTB/RIF introduction in Papua New Guinea, 2012-2017.Public Health Action2019https://conductscience.org/library/papers/31579644PubMed
1633735231Lost to follow-up and associated factors among patients with drug resistant tuberculosis in Ethiopia: A systematic review and meta-analysis.PLoS One2021https://conductscience.org/library/papers/33735231PubMed
1735039860Estimating Tuberculosis Transmission Risks in a Primary Care Clinic in South Africa: Modeling of Environmental and Clinical Data.J Infect Dis2022https://conductscience.org/library/papers/35039860PubMed

Download CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42643644Genomic epidemiology of the Mycobacterium tuberculosis complex in Fiji reveals community transmission and human Mycobacterium bovis infection.Front Microbiol2026https://conductscience.org/library/papers/42643644PubMed
39239155Operational research highlights ongoing challenges for comprehensive TB services in Papua New Guinea.Public Health Action2024https://conductscience.org/library/papers/39239155PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39239161

GET https://conductscience.org/api/papers/v1/39239161/authors